Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt
NCT Number: NCT03507426
This study compares the efficacy and safety of two techniques, retrobulbar block versus intra-operative ketamine infusion, for control of post-operative pain occurring in patients undergoing ocular enucleation or evisceration performed under general anesthesia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cairo, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive a single retrobulbar injection with 3-4ml of an equal mixture of Lidocaine 2% & Bupivacaine 0.5% + Hyaluronidase (10 IU/ml), after induction of general anesthesia.
Other names: Local analgesia
Patients will receive a 0.5 mg/kg bolus followed by an infusion of 0.25 mg/kg/h of intravenous Ketamine, after induction of general anesthesia.
Other names: IV analgesia
Time frame: 24 hours
Time (measured in minutes) elapsed till the patient requires to receive his first post-operative rescue analgesic dose.
Nazmy Edward Seif
Other
Retrobulbar Block Versus Ketamine Infusion as Adjuvants to General Anesthesia for Post-operative Pain Control After Enucleation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05093348
Enucleated; Eye, Evisceration; Traumatic, Eye
London, United Kingdom
View Trial DetailsNCT05236049
Enucleated; Eye, Eye Cancer
Paris, France
View Trial DetailsNCT03925207
Enucleated; Eye
Hangzhou, China
View Trial DetailsNCT03819621
Enucleated; Eye
London, United Kingdom
View Trial Details